Europe Acute Respiratory Distress Syndrome (ARDS) Market is expected to grow with a CAGR of 9.5% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-acute-respiratory-distress-syndrome-ards-market
Europe acute respiratory distress syndrome (ARDS) market is a highly consolidated market, which includes more key players. The market has witnessed increased strategic developments owing to a favorable market scenario.
The major players dealing in Europe acute respiratory distress syndrome (ARDS) market are introducing a strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, and agreement into the market. This helped companies to maximize sales with an enhanced product portfolio.
For instance,
Gilead Sciences Inc. is the dominating player in the Europe acute respiratory distress syndrome (ARDS) market. The other key players existing in the market include Terumo Medical Corporation, Getinge AB., LivaNova PLC, Medtronic, ResMed, Fisher & Paykel Healthcare Limited., F. Hoffmann-La Roche Ltd, Smiths Medical (part of ICU Medical, Inc.), Drägerwerk AG & Co. KGaA, Fresenius SE & Co. KGaA, Hamilton Medical, Pfizer Inc., EUROSETS, Armstrong Medical, nice Neotech Medical Systems Pvt. Ltd., and Besmed Health Business Corp, among others.
Gilead Sciences Inc.
The company focuses on providing and producing antiviral medications, and therapeutics for life-threatening diseases associated with lung injuries and infections. The company also provides medications related to the inflammations associated with ARDS.
For instance,
Terumo Medical Corporation
Terumo Medical Corporation was founded in 1921 headquartered in Japan. The company focuses on providing a large portfolio of medical products associated with various clinical practices such as cardiovascular, general hospitals, and blood cell technologies. The company also provides mechanical ventilations, which are needed for lung injury-related diseases.
For instance,
Getinge AB
The company focuses on providing hospitals and life sciences institutions with various medical products. The company produces mechanical ventilation, which is an absolute necessity for patients who are infected with lung infections associated with ARDS. Hence the company is adding new product features to enhance their quality.
For instance,
Global Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2030
Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
Europe Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
North America Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
Middle East and Africa Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
U.S. Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
Gilead Sciences, Inc., Terumo Medical Corporation, and Getinge AB were Dominating the Global Acute Respiratory Distress Syndrome (ARDS) Market in 2021
Gilead Sciences, Inc., Terumo Medical Corporation, and Getinge AB. dominated the U.S. Acute Respiratory Distress Syndrome (ARDS) Market in 2021
U.S. Acute Respiratory Distress Syndrome (ARDS) Market is Expected to Register a Healthy CAGR in the Forecast Period of 2022 to 2029
Gilead Sciences, Inc., Terumo Medical Corporation and Getinge AB. dominated the Europe, U.S., China, and Japan Acute Respiratory Distress Syndrome (ARDS) Market in 2022